These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8204938

  • 1. [Malignant melanoma of the uvea].
    Boaziz C, Mazeron JJ, Morere JF, Breau JL, Israël L.
    Bull Cancer; 1993 Jul; 80(7):577-83. PubMed ID: 8204938
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
    Voelter V, Schalenbourg A, Pampallona S, Peters S, Halkic N, Denys A, Goitein G, Zografos L, Leyvraz S.
    Melanoma Res; 2008 Jun; 18(3):220-4. PubMed ID: 18477897
    [Abstract] [Full Text] [Related]

  • 3. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
    Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB.
    Br J Cancer; 2002 Oct 07; 87(8):840-5. PubMed ID: 12373596
    [Abstract] [Full Text] [Related]

  • 4. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma.
    Siegel R, Hauschild A, Kettelhack C, Kähler KC, Bembenek A, Schlag PM.
    Eur J Surg Oncol; 2007 Jun 07; 33(5):627-32. PubMed ID: 17196362
    [Abstract] [Full Text] [Related]

  • 5. [Contribution of a new nitrosourea compound: fotemustine].
    Boaziz C.
    Pathol Biol (Paris); 1992 Dec 07; 40(9 Pt 2):964-8. PubMed ID: 1338920
    [Abstract] [Full Text] [Related]

  • 6. Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study.
    Farolfi A, Ridolfi L, Guidoboni M, Milandri C, Calzolari F, Scarpi E, Amadori D, Ridolfi R.
    J Chemother; 2011 Oct 07; 23(5):300-5. PubMed ID: 22005064
    [Abstract] [Full Text] [Related]

  • 7. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
    Schuster R, Lindner M, Wacker F, Krössin M, Bechrakis N, Foerster MH, Thiel E, Keilholz U, Schmittel A.
    Melanoma Res; 2010 Jun 07; 20(3):191-6. PubMed ID: 20335820
    [Abstract] [Full Text] [Related]

  • 8. Metastatic melanoma in the eye and orbit.
    Zografos L, Ducrey N, Beati D, Schalenbourg A, Spahn B, Balmer A, Othenin-Girard CB, Chamot L, Egger E.
    Ophthalmology; 2003 Nov 07; 110(11):2245-56. PubMed ID: 14597536
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and treatment of uveal melanoma.
    Shields JA, Shields CL, De Potter P, Singh AD.
    Semin Oncol; 1996 Dec 07; 23(6):763-7. PubMed ID: 8970600
    [Abstract] [Full Text] [Related]

  • 10. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
    Melichar B, Voboril Z, Lojík M, Krajina A.
    Hepatogastroenterology; 2009 Dec 07; 56(93):1157-62. PubMed ID: 19760961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epidemiology and management of uveal melanoma.
    Yonekawa Y, Kim IK.
    Hematol Oncol Clin North Am; 2012 Dec 07; 26(6):1169-84. PubMed ID: 23116575
    [Abstract] [Full Text] [Related]

  • 13. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
    Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.
    Ann Oncol; 2014 Mar 07; 25(3):742-746. PubMed ID: 24510314
    [Abstract] [Full Text] [Related]

  • 14. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y, Wilson MW.
    Curr Opin Ophthalmol; 2009 Nov 07; 20(6):504-10. PubMed ID: 19644367
    [Abstract] [Full Text] [Related]

  • 15. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S, Hendler K, Pe'er J.
    Isr Med Assoc J; 2009 May 07; 11(5):280-5. PubMed ID: 19637505
    [Abstract] [Full Text] [Related]

  • 16. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
    Augsburger JJ, Corrêa ZM, Freire J, Brady LW.
    Ophthalmology; 1998 Sep 07; 105(9):1670-8. PubMed ID: 9754176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.
    Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L.
    J Clin Oncol; 1997 Jul 07; 15(7):2589-95. PubMed ID: 9215829
    [Abstract] [Full Text] [Related]

  • 19. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T.
    Ophthalmology; 2003 Nov 07; 110(11):2223-34. PubMed ID: 14597534
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients.
    Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD.
    Int J Clin Oncol; 2001 Feb 07; 6(1):25-8. PubMed ID: 11706523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.